or
forgot password
  • cancer clinical trials in memphis, TN

  • Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Hepatic Veno-Occlusive Disease
    Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, T-Cell, Juvenile Myelomonocytic Leukemia Lymphoblastic, T-cell Lymphoblastic Lymphoma, Myelodysplastic Syndrome
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    University of Tennessee - Memphis
    Memphis, Tennessee 38163
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    University of Tennessee Cancer Institute - Memphis
    Memphis, Tennessee 38104
    Leukemia
    Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Refractory Solid Tumors, Leukemia
    A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
    St Jude Children's Research Hospital
    Memphis, Tennessee 38105
    Osteosarcoma, Malignant Fibrous Histiocytoma (MFH) of Bone
    Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Protocol For Collecting Data On Patients With Childhood Cancer
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Childhood Cancer
    Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Memphis, Tennessee 38138
    Non Small Cell Lung Cancer
    Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Severe Combined Immunodeficiency, Malignancy, Hematologic, Neuroblastoma, Neoplasm, Mucopolysaccharidosis I
    Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma
    International Pediatric Adrenocortical Tumor Registry
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Adrenocortical Tumor
    Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer
    ImClone Investigational Site
    Memphis, Tennessee 38104
    Breast Cancer
    Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Non-Hodgkins Lymphoma, Hodgkin's Disease, Acute Lymphoblastic Leukemia
    BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
    1200.36.0020 Boehringer Ingelheim Investigational Site
    Memphis, Tennessee
    Glioma
    A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer
    ImClone Investigational Site
    Memphis, Tennessee 38104
    Metastatic Breast Cancer
    Pharmacogenetic Determinants Of Treatment Response In Children
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    All Malignancies, Children Being Treated for Catastrophic Illness
    Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
    The West Clinic
    Memphis, Tennessee 38120
    Pancreatic Cancer
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    MLN8237 in Young Patients With Relapsed or Refractory Solid Tumors or Acute Lymphoblastic Leukemia
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Leukemia, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
    A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma Or Melanoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Neuroblastoma, Melanoma, Osteosarcoma
    Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Prostatic Neoplasms
    A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Osteosarcoma
    A Trial of RAD001 and Avastin in Children With Recurrent Solid Tumors
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Recurrent or Refractory Solid Tumors, CNS Malignancies
    Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Cancer
    A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Memphis, Tennessee 38138
    Non-small Cell Lung Cancer
    Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer
    HIFU Site: Southeast Urology Network
    Memphis, Tennessee 38119
    Prostate Cancer
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.
    University of Tennessee Cancer Institute

    Trial Locations
    University of Tennessee Cancer Institute
    The West Clinic
    Breast Cancer
    Salvage Cryotherapy in Recurrent Prostate Cancer
    University of Tennessee Cancer Institute - Memphis
    Memphis, Tennessee 38104
    Recurrent Prostate Cancer
    Efficacy of Tobacco Quitline for Cancer Survivors
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Smoking Cessation
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Veterans Affairs Medical Center - Memphis

    Trial Locations
    Veterans Affairs Medical Center - Memphis
    University of Tennessee - Memphis
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Long Term Effects of Erythrocyte Lysis
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Sickle Cell Disease, Hemolytic Anemia
    Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Non-small Cell Lung Cancer (NSCLC)
    Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
    University of Tennessee Cancer Institute

    Trial Locations
    University of Tennessee Cancer Institute
    Accelerated Community Oncology Reseaerch Network, Inc. (ACORN)
    Peripheral T-cell Lymphoma
    A Feasibility Study of SAHA Combined With Isotretinoin and Chemotherapy in Infants With Embryonal Tumors of the Central Nervous System
    St. Jude Children's Research Hospital

    Trial Locations
    St. Jude Children's Research Hospital
    Pediatric Brain Tumor Consortium
    Untreated Childhood Medulloblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Study of Kidney Tumors in Young Patients
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Kidney Cancer, Nonneoplastic Condition
    DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Brain Tumors, Central Nervous System Tumors
    Physical Activity to Modify Sequelae and Quality of Life in Childhood Acute Lymphoblastic Leukemia
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Acute Lymphoblastic Leukemia
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Neuroblastoma
    Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Acute Myeloid Leukemia, Infantile Leukemia (Both AML and ALL), Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasms, Biphenotypic Leukemia
    Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Patients With Gastric Cancer and Adenocarcinoma
    ImClone Investigational Site
    Memphis, Tennessee 38104
    Gastric Cancer, Adenocarcinoma
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    University of Tennessee Cancer Institute - Memphis
    Memphis, Tennessee 38104
    Lung Cancer
    Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
    University of Tennessee Cancer Institute

    Trial Locations
    University of Tennessee Cancer Institute
    The West Clinic
    Metastatic Breast Cancer
    Vismodegib in Treating Patients With Recurrent or Refractory Medulloblastoma
    Pediatric Brain Tumor Consortium
    Memphis, Tennessee 38105
    Adult Medulloblastoma
    Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
    The West Clinic Dept. of the West Clinic
    Memphis, Tennessee 38120
    Myelodysplastic Syndromes